Form 8-K - Current report:
SEC Accession No. 0001104659-24-109401
Filing Date
2024-10-17
Accepted
2024-10-17 09:15:24
Documents
20
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426316d1_8k.htm   iXBRL 8-K 37592
2 EXHIBIT 10.1 tm2426316d1_ex10-1.htm EX-10.1 396145
3 EXHIBIT 10.2 tm2426316d1_ex10-2.htm EX-10.2 193508
4 EXHIBIT 10.3 tm2426316d1_ex10-3.htm EX-10.3 124922
5 EXHIBIT 10.4 tm2426316d1_ex10-4.htm EX-10.4 229655
6 EXHIBIT 10.5 tm2426316d1_ex10-5.htm EX-10.5 63258
7 EXHIBIT 10.6 tm2426316d1_ex10-6.htm EX-10.6 29626
8 EXHIBIT 10.7 tm2426316d1_ex10-7.htm EX-10.7 36973
  Complete submission text file 0001104659-24-109401.txt   1534153

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rsls-20241016.xsd EX-101.SCH 3048
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20241016_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20241016_pre.xml EX-101.PRE 22381
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2426316d1_8k_htm.xml XML 3572
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 241376105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)